Organized by the MSF Access Campaign, this roundtable – the second in this series – aims to explore practical implementation of disclosing clinical trial costs: why should this be done and how.
Moderator: Rachel Cohen, North America Director, DNDi
Speakers:
- Christopher Morten, Founding Director, Columbia Law School’s Science, Health, and Information Clinic
- Bern-Thomas Nyang’wa, Medical Director, MSF; Chief investigator, MSF TB PRACTECAL
- Rory Collins, BHF Professor of Medicine & Epidemiology and Head of the Nuffield Department of Population Health, Oxford University; Principle Investigator, UK Biobank
- Duduzile Ndwandwe, Deputy Director and Vaccinologist, Cochrane South Africa, South African Medical Research Council (SAMRC); Lead, Clinical Trials Registry portfolio (Pan African Clinical Trials Registry (PACTR) and South African National Clinical Trials Registry (SANCTR))
- Fatima Hassan, Human rights lawyer, social justice activist, Founder of the Health Justice Initiative (HJI)
